Resources with keywords: rebound
SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals (NEW 1/18, Website)
CDC/MMWR
22 December 2023
Smith DJ, Lambrou A, Patel P
After anti-viral treatment, no consistent association between treatment and rebound was identified.
Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study (Website)
The Lancet: Infectious Diseases
13 February 2023
The Lancet: Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study. Wong, C., et.al. (Feb 13, 2023)
Wong, C., et.al.
Viral burden rebound rates are similar between patients with antiviral treatment and those without. Importantly, viral burden rebound was not associated with adverse clinical outcomes.
